首页 | 本学科首页   官方微博 | 高级检索  
检索        

肺癌患者外周血 T- 淋巴细胞亚群 NK 细胞的基线数值及其与预后的关系*
引用本文:李月雅,张翠翠,魏熙胤,王心悦,李凯.肺癌患者外周血 T- 淋巴细胞亚群 NK 细胞的基线数值及其与预后的关系*[J].中国肿瘤临床,2016,43(5):204-210.
作者姓名:李月雅  张翠翠  魏熙胤  王心悦  李凯
作者单位:作者单位:①天津医科大学肿瘤医院肺部肿瘤内科,国家肿瘤临床医学研究中心,天津市肿瘤防治重点实验室,天津市肺癌诊治中心(天津市 300060);②肿瘤研究所公共实验室
基金项目:This study was supported by the National Science and Technology Major Project(2013ZX09303001),Tianjin Municipal Science and Technology Project(12ZCDZSY15600),Chinese Society of Clinical Oncology (CSCO) Research Fund Project (No.Y-S2014-011)*本文课题受国家科技重大专项(编号2013ZX09303001),天津市科委抗癌重大专项攻关计划(编号12ZCDZSY15600),CSCO研究基金项目(编号Y-S2014-011)
摘    要:目的:对比肺癌患者与健康者之间淋巴细胞亚群差异,评估肺癌患者外周血T 淋巴细胞亚群及自然杀伤细胞(NK)之基线值与预后的关系。方法:收集2006年2 月至2013年3 月就诊于天津医科大学肿瘤医院病例资料完整的肺癌患者105 例,其中非小细胞肺癌(NSCLC )86例、小细胞肺癌(SCLC)19例,另选健康对照35例,对比接受治疗前肺癌患者和健康对照者外周血中的CD3+T 细胞、CD4+T 细胞、CD8+T 细胞及NK细胞所占百分比,并回顾性分析86例NSCLC 患者初治时外周血淋巴细胞亚群与预后的关系。结果:肺癌患者外周血CD3+T 细胞、CD4+T 细胞、NK细胞及CD4/CD 8 比值均明显低于健康对照组(P = 0.011,P = 0.007,P <0.001,P=0.025),而CD8+T 细胞比例高于健康对照组(P = 0.013)。 当CD8+T ≥ 31.8% 及CD4/CD 8< 1.28时NSCLC 患者可以获得一个更长的OS(中位OS分别为36.2 m vs . 20.0 m ,P = 0.010;30.8 m vs . 20.0 m ,P = 0.035)。 而CD3+T 细胞、CD4+T 细胞及NK细胞百分比对NSCLC 患者预后无显著影响。结论:外周血CD8+T 细胞基线水平较高的NSCLC 患者生存较长,此基线水平可能对NSCLC 患者预后有指示作用。 

关 键 词:肺癌    非小细胞肺癌    淋巴细胞亚群    NK细胞    CD4+T  细胞    CD8+T  细胞    CD4/CD  8  比值
收稿时间:2015-12-03

Base amount of blood T-lymphocyte subsets and NK cells in patients with lung cancer and its value in predicting prognosis
Institution:1Departments of Thoracic Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin Lung Cancer Diagnosis and Treatment Centre, Tianjin 300060, China;
Abstract:Objective: To predict survival outcome, the lymphocyte subsets between lung cancer patients and healthy subjects was compared, and the significance of T-lymphocyte subgroups and NK cell base amount in the peripheral blood of lung cancer patients was evaluated. Methods:The percentage of CD3+T, CD4+T, CD8+T, and natural killer (NK) cells in the peripheral blood of 105 patients with lung cancer and 35 healthy subjects were analyzed by flow cytometry. Among the 105 patients, 19 cases were small cell lung can-cer (SCLC) and 86 cases were non-small cell lung cancer (NSCLC). The lymphocyte levels of the subgroups were recorded, and the rela-tionship between lymphocyte subsets of 86 NSCLC patients and survival outcome was analyzed retrospectively. Results:The levels of CD3+, CD4+, NK cells and the ratio of CD4/CD8 in patients have respective P values of 0.011, 0.007,<0.001, 0.025, which were signifi-cantly lower than that in normal subjects. However, the proportion of CD8+increased remarkably in patients (P=0.013). The overall sur-vival (OS) was more longer when CD8+T were≥31.8%of NSCLC patients, and the ratio of CD4/CD8 were less than 1.28 of NSCLC pa-tients (mean OS 36.2 m vs. 20.0 m, P=0.010;30.8 m vs. 20.0 m, P=0.035, respectively). However, the percentage of CD3+, CD4+, and NK cells had an insignificant effect in predicting the prognosis of NSCLC patients. Conclusion:High basal levels of CD8+T cells in peripheral blood could prolong the survival of patients with NSCLC. Furthermore, evaluating the basal levels of CD8+T cells by flow cytometry in peripheral blood might provide prognostic information.
Keywords:lung cancer  non-small cell lung cancer  lymphocyte subsets  NK cells  CD4-positive T-lymphocyte  CD8-positive T-lympho-cyte  CD4-CD8 ratios
本文献已被 万方数据 等数据库收录!
点击此处可从《中国肿瘤临床》浏览原始摘要信息
点击此处可从《中国肿瘤临床》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号